Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UBE2N - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LCAT - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
PPP1R1B - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
ARF3 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
THOC2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
NDC1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
DOCK8 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SUPT16H - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
NUDT5 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
ANLN - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
ZNF207 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
PPP2R5C - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
TPGS2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CDK1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
IDO1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
AGPAT5 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CEBPB - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
RAB27B - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
HNRNPU - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CNPPD1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on